A phase II trial of ipilimumab with and without nivolumab in patients with relapsed/refractory classic Hodgkin lymphoma
NOT ENROLLING
Trial ID:
NCT04938232 Protocol # :
21-204
Phase
II
Disease Sites
Hodgkin's Lymphoma
Principal Investigator
Merryman, Reid, W
Site Research Nurses
Brennan, Lisa
Bresnahan, Caitlin
Carmichael, Amanda, E.
Chung, Anita
Kats, Vanessa
Kilcommons, Marykate
McRoberts, Kaleigh
Normilus, Samantha
Patterson, Victoria
Plummer, Sean, F.
Re, Sandra
Silva, Wendy, Ann
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-204
21-204